These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34341958)

  • 1. Revising Pharmacokinetics of Oral Drug Absorption: II Bioavailability-Bioequivalence Considerations.
    Chryssafidis P; Tsekouras AA; Macheras P
    Pharm Res; 2021 Aug; 38(8):1345-1356. PubMed ID: 34341958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-writing Oral Pharmacokinetics Using Physiologically Based Finite Time Pharmacokinetic (PBFTPK) Models.
    Chryssafidis P; Tsekouras AA; Macheras P
    Pharm Res; 2022 Apr; 39(4):691-701. PubMed ID: 35378697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Columbus' egg: Oral drugs are absorbed in finite time.
    Macheras P; Tsekouras AA
    Eur J Pharm Sci; 2022 Sep; 176():106265. PubMed ID: 35863551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revamping Biopharmaceutics-Pharmacokinetics with Scientific and Regulatory Implications for Oral Drug Absorption.
    Alimpertis N; Tsekouras AA; Macheras P
    Pharm Res; 2023 Sep; 40(9):2167-2175. PubMed ID: 37537424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IVIVC Revised.
    Alimpertis N; Simitopoulos A; Tsekouras AA; Macheras P
    Pharm Res; 2024 Feb; 41(2):235-246. PubMed ID: 38191705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physiologically based Pharmacokinetic Models under the Prism of the Finite Absorption Time Concept.
    Wu D; Tsekouras AA; Macheras P; Kesisoglou F
    Pharm Res; 2023 Feb; 40(2):419-429. PubMed ID: 36050545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of the Finite Absorption Time (F.A.T.) Concept in the Assessment of Bioequivalence.
    Tsekouras AA; Macheras P
    Pharm Res; 2024 Jul; 41(7):1413-1425. PubMed ID: 38898304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physiologically Based Pharmacokinetic Modeling of Oral Absorption, pH, and Food Effect in Healthy Volunteers to Drive Alpelisib Formulation Selection.
    Gajewska M; Blumenstein L; Kourentas A; Mueller-Zsigmondy M; Lorenzo S; Sinn A; Velinova M; Heimbach T
    AAPS J; 2020 Oct; 22(6):134. PubMed ID: 33070288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorption rate vs. exposure: which is more useful for bioequivalence testing?
    Tozer TN; Bois FY; Hauck WW; Chen ML; Williams RL
    Pharm Res; 1996 Mar; 13(3):453-6. PubMed ID: 8692741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population Analysis.
    Ameijeiras Rodríguez C; Henriques SC; Sancho-Araiz A; Trocóniz IF; Almeida L; Silva NE
    Pharm Res; 2021 Dec; 38(12):2047-2063. PubMed ID: 34932170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Impacts of Formulation Parameters on the Pharmacokinetics and Bioequivalence of Risperidone Orodispersible Film: a Physiologically Based Pharmacokinetic Modeling Approach.
    Chen F; Liu H; Wang B; Yang Z; Chen Y; Yang L; Wang B; Jiao Z; Lin HS; Quan Y; Wang H; Xiang X
    AAPS PharmSciTech; 2020 Aug; 21(7):245. PubMed ID: 32856178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioequivalence Comparison of Pediatric Dasatinib Formulations and Elucidation of Absorption Mechanisms Through Integrated PBPK Modeling.
    Vaidhyanathan S; Wang X; Crison J; Varia S; Gao JZH; Saxena A; Good D
    J Pharm Sci; 2019 Jan; 108(1):741-749. PubMed ID: 30439460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the role of metabolites in bioequivalence assessment.
    Karalis V; Macheras P
    J Pharm Pharm Sci; 2010; 13(2):198-217. PubMed ID: 20816006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of different indirect measures of rate of drug absorption in comparative pharmacokinetic studies.
    Lacey LF; Keene ON; Duquesnoy C; Bye A
    J Pharm Sci; 1994 Feb; 83(2):212-5. PubMed ID: 8169791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
    Weiss M
    Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In silico drug absorption tract: An agent-based biomimetic model for human oral drug absorption.
    Deng J; Jhandey A; Zhu X; Yang Z; Yik KFP; Zuo Z; Lam TN
    PLoS One; 2018; 13(8):e0203361. PubMed ID: 30169515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revising Pharmacokinetics of Oral Drug Absorption: I Models Based on Biopharmaceutical/Physiological and Finite Absorption Time Concepts.
    Macheras P; Chryssafidis P
    Pharm Res; 2020 Sep; 37(10):187. PubMed ID: 32888087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of bioequivalence of a new fixed-dose combination of acarbose and metformin with the corresponding loose combination as well as the drug-drug interaction potential between both drugs in healthy adult male subjects.
    Kim S; Jang IJ; Shin D; Shin DS; Yoon S; Lim KS; Yu KS; Li J; Zhang H; Liu Y; Brendel E; Blode H; Wang Y
    J Clin Pharm Ther; 2014 Aug; 39(4):424-31. PubMed ID: 24806030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cmax/AUC is a clearer measure than Cmax for absorption rates in investigations of bioequivalence.
    Endrenyi L; Fritsch S; Yan W
    Int J Clin Pharmacol Ther Toxicol; 1991 Oct; 29(10):394-9. PubMed ID: 1748540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.